8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with n-methylquipazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S | 1 |
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J | 1 |
1 review(s) available for 8-hydroxy-2-(di-n-propylamino)tetralin and n-methylquipazine
Article | Year |
---|---|
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin | 2022 |
1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and n-methylquipazine
Article | Year |
---|---|
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |